Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Recombinant Peptides industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Hospira
Cipla Ltd
Biocon Ltd
Wockhardt Ltd
Amgen
Sandoz Pharma
Actavis
By Type:
Other
Calcitonin
Glucagon
By Application:
Human Growth Hormone
Insulin
Other
Blood Products
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Recombinant Peptides Market Overview 2018-2029
-
1.1 China Recombinant Peptides Industry Development Overview
-
1.2 China Recombinant Peptides Industry Development History
-
1.3 China Recombinant Peptides Industry Market Size (2018-2029)
-
1.4 China Recombinant Peptides Market Analysis by Type from Production Side
-
1.4.1 China Recombinant Peptides Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
1.4.2 China Recombinant Peptides Production Volume, Production Value and Growth Rate of Calcitonin (2018-2029)
-
1.4.3 China Recombinant Peptides Production Volume, Production Value and Growth Rate of Glucagon (2018-2029)
-
1.5 China Recombinant Peptides Market Analysis by Application from Consumption End
-
1.5.1 China Recombinant Peptides Sales Volume, Sales Value and Growth Rate of Human Growth Hormone (2018-2029)
-
1.5.2 China Recombinant Peptides Sales Volume, Sales Value and Growth Rate of Insulin (2018-2029)
-
1.5.3 China Recombinant Peptides Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.4 China Recombinant Peptides Sales Volume, Sales Value and Growth Rate of Blood Products (2018-2029)
-
1.6 China Recombinant Peptides Market Analysis by Region
-
1.6.1 North China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Recombinant Peptides Market Size and Growth Rate from 2018-2029
Chapter 2 China Recombinant Peptides Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Recombinant Peptides Market Status and Competition at home and abroad in 2023
-
2.2.2 China Recombinant Peptides Market Status and Competition Analysis in 2023
-
2.2.3 China Recombinant Peptides Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Recombinant Peptides Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Recombinant Peptides Industry Development
Chapter 3 Recombinant PeptidesIndustry Chain Analysis
-
3.1 Recombinant Peptides Industry Chain
-
3.2 Recombinant Peptides Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Recombinant Peptides Market
-
3.3 Recombinant Peptides Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Recombinant Peptides Market
Chapter 4 China Recombinant Peptides Market, by Type
-
4.1 China Recombinant Peptides Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Recombinant Peptides Total Production Volume and Growth Rate from Production Side
-
4.5 China Recombinant Peptides Production Volume and Growth Rate, by Type
-
4.5.1 China Recombinant Peptides Production Volume and Growth Rate of Other
-
4.5.2 China Recombinant Peptides Production Volume and Growth Rate of Calcitonin
-
4.5.3 China Recombinant Peptides Production Volume and Growth Rate of Glucagon
Chapter 5 China Recombinant Peptides Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Recombinant Peptides Total Market Size and Growth Rate from Consumption End
-
5.5 China Recombinant Peptides Market Size and Growth Rate, by Application
-
5.5.1 China Recombinant Peptides Market Size and Growth Rate of Human Growth Hormone
-
5.5.2 China Recombinant Peptides Market Size and Growth Rate of Insulin
-
5.5.3 China Recombinant Peptides Market Size and Growth Rate of Other
-
5.5.4 China Recombinant Peptides Market Size and Growth Rate of Blood Products
Chapter 6 China Recombinant Peptides Market, by Region
-
6.1 China Recombinant Peptides Production Volume and Production Value, by Region
-
6.2 China Recombinant Peptides Sales Volume and Sales Value, by Region
Chapter 7 North China Recombinant Peptides Market Analysis
-
7.1 North China Recombinant Peptides Market, by Type
-
7.2 North China Recombinant Peptides Market, by Application
Chapter 8 Central China Recombinant Peptides Market Analysis
-
8.1 Central China Recombinant Peptides Market, by Type
-
8.2 Central China Recombinant Peptides Market, by Application
Chapter 9 South China Recombinant Peptides Market Analysis
-
9.1 South China Recombinant Peptides Market, by Type
-
9.2 South China Recombinant Peptides Market, by Application
Chapter 10 East China Recombinant Peptides Market Analysis
-
10.1 East China Recombinant Peptides Market, by Type
-
10.2 East China Recombinant Peptides Market, by Application
Chapter 11 Northeast China Recombinant Peptides Market Analysis
-
11.1 Northeast China Recombinant Peptides Market, by Type
-
11.2 Northeast China Recombinant Peptides Market, by Application
Chapter 12 Southwest China Recombinant Peptides Market Analysis
-
12.1 Southwest China Recombinant Peptides Market, by Type
-
12.2 Southwest China Recombinant Peptides Market, by Application
Chapter 13 Northwest China Recombinant Peptides Market Analysis
-
13.1 Northwest China Recombinant Peptides Market, by Type
-
13.2 Northwest China Recombinant Peptides Market, by Application
Chapter 14 Company Profiles
-
14.1 Hospira
-
14.1.1 Hospira Company Profile
-
14.1.2 Hospira Recombinant Peptides Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Cipla Ltd
-
14.2.1 Cipla Ltd Company Profile
-
14.2.2 Cipla Ltd Recombinant Peptides Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Biocon Ltd
-
14.3.1 Biocon Ltd Company Profile
-
14.3.2 Biocon Ltd Recombinant Peptides Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Wockhardt Ltd
-
14.4.1 Wockhardt Ltd Company Profile
-
14.4.2 Wockhardt Ltd Recombinant Peptides Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Amgen
-
14.5.1 Amgen Company Profile
-
14.5.2 Amgen Recombinant Peptides Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Sandoz Pharma
-
14.6.1 Sandoz Pharma Company Profile
-
14.6.2 Sandoz Pharma Recombinant Peptides Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Actavis
-
14.7.1 Actavis Company Profile
-
14.7.2 Actavis Recombinant Peptides Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Recombinant Peptides Industry Research Conclusions
-
15.2 Recombinant Peptides Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Recombinant Peptides Industry Market Size (2018-2029)
-
Figure China Recombinant Peptides Production Volume, Production Value and Growth Rate of Other (2018-2029)
-
Figure China Recombinant Peptides Production Volume, Production Value and Growth Rate of Calcitonin (2018-2029)
-
Figure China Recombinant Peptides Production Volume, Production Value and Growth Rate of Glucagon (2018-2029)
-
Figure China Recombinant Peptides Sales Volume, Sales Value and Growth Rate of Human Growth Hormone (2018-2029)
-
Figure China Recombinant Peptides Sales Volume, Sales Value and Growth Rate of Insulin (2018-2029)
-
Figure China Recombinant Peptides Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Recombinant Peptides Sales Volume, Sales Value and Growth Rate of Blood Products (2018-2029)
-
Figure North China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
Figure Central China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
Figure South China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
Figure East China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Recombinant Peptides Market Size and Growth Rate from 2018-2029
-
Figure Recombinant Peptides Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Recombinant Peptides Market Share by Type in 2018
-
Figure China Recombinant Peptides Market Share by Type in 2023
-
Figure China Recombinant Peptides Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Recombinant Peptides Production Volume and Growth Rate of Other (2018-2023)
-
Figure China Recombinant Peptides Production Volume and Growth Rate of Calcitonin (2018-2023)
-
Figure China Recombinant Peptides Production Volume and Growth Rate of Glucagon (2018-2023)
-
Figure China Recombinant Peptides Market Share by Application in 2018
-
Figure China Recombinant Peptides Market Share by Application in 2023
-
Figure China Recombinant Peptides Total Market Size and Growth Rate from Consumption End
-
Figure China Recombinant Peptides Market Size and Growth Rate of Human Growth Hormone (2018-2023)
-
Figure China Recombinant Peptides Market Size and Growth Rate of Insulin (2018-2023)
-
Figure China Recombinant Peptides Market Size and Growth Rate of Other (2018-2023)
-
Figure China Recombinant Peptides Market Size and Growth Rate of Blood Products (2018-2023)
-
Table China Recombinant Peptides Production Volume by Region (2018-2023)
-
Table China Recombinant Peptides Production Volume Share by Region (2018-2023)
-
Figure China Recombinant Peptides Production Volume Share by Region (2018-2023)
-
Table China Recombinant Peptides Production Value by Region (2018-2023)
-
Table China Recombinant Peptides Production Value Share by Region (2018-2023)
-
Figure China Recombinant Peptides Production Value Share by Region (2018-2023)
-
Table China Recombinant Peptides Sales Volume by Region (2018-2023)
-
Table China Recombinant Peptides Sales Volume Share by Region (2018-2023)
-
Figure China Recombinant Peptides Sales Volume Share by Region (2018-2023)
-
Table China Recombinant Peptides Sales Value by Region (2018-2023)
-
Table China Recombinant Peptides Sales Value Share by Region (2018-2023)
-
Figure China Recombinant Peptides Sales Value Share by Region (2018-2023)
-
Table North China Recombinant Peptides Production Volume by Type (2018-2023)
-
Table North China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Figure North China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Table North China Recombinant Peptides Sales Volume by Application (2018-2023)
-
Table North China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Figure North China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Table Central China Recombinant Peptides Production Volume by Type (2018-2023)
-
Table Central China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Figure Central China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Table Central China Recombinant Peptides Sales Volume by Application (2018-2023)
-
Table Central China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Figure Central China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Table South China Recombinant Peptides Production Volume by Type (2018-2023)
-
Table South China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Figure South China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Table South China Recombinant Peptides Sales Volume by Application (2018-2023)
-
Table South China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Figure South China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Table East China Recombinant Peptides Production Volume by Type (2018-2023)
-
Table East China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Figure East China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Table East China Recombinant Peptides Sales Volume by Application (2018-2023)
-
Table East China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Figure East China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Table Northeast China Recombinant Peptides Production Volume by Type (2018-2023)
-
Table Northeast China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Figure Northeast China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Table Northeast China Recombinant Peptides Sales Volume by Application (2018-2023)
-
Table Northeast China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Table Southwest China Recombinant Peptides Production Volume by Type (2018-2023)
-
Table Southwest China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Figure Southwest China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Table Southwest China Recombinant Peptides Sales Volume by Application (2018-2023)
-
Table Southwest China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Table Northwest China Recombinant Peptides Production Volume by Type (2018-2023)
-
Table Northwest China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Figure Northwest China Recombinant Peptides Production Volume Share by Type (2018-2023)
-
Table Northwest China Recombinant Peptides Sales Volume by Application (2018-2023)
-
Table Northwest China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Recombinant Peptides Sales Volume Share by Application (2018-2023)
-
Table Hospira Company Profile
-
Table Hospira Recombinant Peptides Revenue, Price and Gross (2018-2023)
-
Table Cipla Ltd Company Profile
-
Table Cipla Ltd Recombinant Peptides Revenue, Price and Gross (2018-2023)
-
Table Biocon Ltd Company Profile
-
Table Biocon Ltd Recombinant Peptides Revenue, Price and Gross (2018-2023)
-
Table Wockhardt Ltd Company Profile
-
Table Wockhardt Ltd Recombinant Peptides Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Recombinant Peptides Revenue, Price and Gross (2018-2023)
-
Table Sandoz Pharma Company Profile
-
Table Sandoz Pharma Recombinant Peptides Revenue, Price and Gross (2018-2023)
-
Table Actavis Company Profile
-
Table Actavis Recombinant Peptides Revenue, Price and Gross (2018-2023)
-
